Screener
Tango Therapeutics TNGX PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Tango Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Tango Therapeutics’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-221656
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Restricted cash | — | 428 |
| Prepaid expenses and other current assets | 12,488 | 10,190 |
| Total current assets | 392,327 | 353,756 |
| Property and equipment, net | 6,381 | 6,868 |
| Operating lease right-of-use assets | 34,652 | 35,624 |
| Restricted cash, net of current portion | 2,139 | 2,139 |
| Other assets | 293 | 303 |
| Total assets | $435,792 | $398,690 |
Item 1. Financial Statements.
FAQ
- What is Tango Therapeutics's PP&E (net)?
- Tango Therapeutics (TNGX) reported PP&E (net) of $6.38M in Q1 2026.
- How has Tango Therapeutics's PP&E (net) changed year-over-year?
- Tango Therapeutics's PP&E (net) decreased by 15.4% year-over-year, from $7.54M to $6.38M.
- What is the long-term trend for Tango Therapeutics's PP&E (net)?
- Over 5 years (2020 to 2025), Tango Therapeutics's PP&E (net) has grown at a 12.4% compound annual growth rate (CAGR), from $3.82M to $6.87M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Tango Therapeutics's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude